Trends in Pharmacological Sciences

Trends in Pharmacological Sciences is a monthly peer-reviewed reviews journal published by Cell Press and founded in 1979, covering pharmacology, pharmacy, pharmaceutics and toxicology, with a 2025 Journal Impact Factor of 24.0《药理学趋势》是（Cell Press）出版的一份月度同行评审综述期刊，1979 年创办，涵盖药理学、药学、药剂学与毒理学，2025 年影响因子为 24.0。

Scope

• It publishes reviews and opinions that survey the most exciting recent developments in pharmacology and therapeutics research该刊发表综述与观点文章，评述药理学与治疗学研究中最受关注的最新进展。
• Its topics include drug discovery and development, such as drug design, target identification and validation, and drug delivery其主题包括药物发现与开发，如药物设计、靶点识别与验证，以及药物递送。
• It also covers basic and clinical pharmacology, drug mechanisms, receptors, enzymes, ion channels, transporters and pharmacokinetics该刊还涵盖基础与临床药理学、药物机制、受体、酶、离子通道、转运体与药代动力学。
• Therapeutics content spans gene-based, cell-based and protein-based therapy, drug classes, routes of administration and drug nomenclature治疗学内容涵盖基因治疗、细胞治疗与蛋白治疗，以及药物类别、给药途径与药物命名。
• Drug safety and toxicity are covered too, including drug-drug interactions, adverse drug reactions and pharmacovigilance药物安全与毒性亦在涵盖之列，包括药物相互作用、不良反应与药物警戒。
• Articles on pharmacy, pharmacoepidemiology and pharmacoeconomics, and on the biopharma regulatory landscape, are also welcome该刊同样欢迎关于药学、药物流行病学与药物经济学，以及生物医药监管格局的文章。

History

• The journal was launched in 1979 as one of the Trends journals published by Elsevier该刊于 1979 年创刊，是（Elsevier）旗下（Trends）系列期刊之一。
• It established a format of succinct articles reporting the most exciting recent developments in pharmacology and therapeutics它确立了以精炼短文报道药理学与治疗学最新进展的栏目形式。
• It is published by Cell Press, the life and physical sciences imprint of Elsevier based in Cambridge, Massachusetts该刊由（Cell Press）出版，后者是（Elsevier）位于美国马萨诸塞州剑桥的生命与物理科学出版品牌。
• A 1991 review by John Hardy and David Allsop discussed amyloid deposition as the central event in the aetiology of Alzheimer's disease1991 年由 John Hardy 与 David Allsop 撰写的综述，论述了淀粉样蛋白沉积作为阿尔茨海默病病因核心事件的观点。^[1]
• A 2012 review by Gregg Semenza addressed hypoxia-inducible factors as targets for cancer therapy2012 年由 Gregg Semenza 撰写的综述，探讨了缺氧诱导因子作为癌症治疗靶点。^[2]
• Its 2025 Journal Impact Factor is 24.0, up from 19.9 in 2024其 2025 年影响因子为 24.0，高于 2024 年的 19.9。

Editors

• Reviews and opinions are usually invited by the editor, Jerry Madukwe, though the journal also welcomes suggestions from the community综述与观点文章通常由编辑 Jerry Madukwe 邀约，该刊也欢迎学界主动提议。
• The journal is guided by an advisory board of about 20 members drawn from nine countries and regions该刊由一个约 20 名成员、来自九个国家和地区的顾问委员会指导。
• Members of the advisory board include the Nobel laureate Brian Kobilka of Stanford University and Michelle Arkin of the University of California, San Francisco顾问委员会成员包括（Stanford University）的诺贝尔奖得主 Brian Kobilka 与加州大学旧金山分校的 Michelle Arkin。
• Other board members include Jeffrey Benovic, Magnus Ingelman-Sundberg, Michel Lazdunski, Fiona Marshall and Ming-Wei Wang of Fudan University其他编委包括 Jeffrey Benovic、Magnus Ingelman-Sundberg、Michel Lazdunski、Fiona Marshall，以及（Fudan University）的 Ming-Wei Wang。
• Most board members are based in the United States, with others in Australia, the United Kingdom and across Europe and Asia多数编委来自美国，其余分布于澳大利亚、英国以及欧洲和亚洲各地。
• As a Trends review journal, TIPS is handled by the professional editorial team of Cell Press作为（Trends）系列综述刊，（TIPS）由（Cell Press）的专业编辑团队负责编辑。